
TAp63: A new protein drug target for rheumatoid arthritis
Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint deterioration. The clinical outcomes of patients with active RA can be improved using anti-rheumatic medications, such as methotrexate (MTX). Many ...
May 22, 2023
0
0